Huma.AI is a transformative force in the healthcare industry, blending human intuition with machine capabilities. The company's self-service business intelligence platform, designed specifically for healthcare, employs AI-driven knowledge automation to provide instantaneous answers to data queries - drawing from the founder's expertise at Novartis. This innovation aims to facilitate data-informed, timely decisions, expediting the development of life-saving drugs, devices, and diagnostics. The platform's seamless usability, akin to Alexa, coupled with robust business intelligence, sets it apart: it's user-friendly, adaptable to diverse data locations, and can process structured and unstructured data formats. Currently collaborating with major players in the life sciences sphere, the United States-based Huma.AI has received non-equity assistance investment from PharmStars in December 2022.
No recent news or press coverage available for Huma.ai.